3100
J.S. Schneekloth et al. / Tetrahedron 65 (2009) 3096–3101
1051 cmꢂ1; 1H NMR (500 MHz, CDCl3)
d
7.53 (br s, N–H, 1H), 6.36 (s,
119.2, 115.8, 108.5, 60.4, 54.4, 30.6, 16.1, 14.5; HRMS (ESI-TOF)
C
1H), 6.14 (s,1H), 3.87 (s, 3H), 3.80 (s, 3H), 2.71 (apt, J¼8.1 Hz, 2H),1.61
16H23N2O2S calculated for [MþH]þ 307.1480, found 307.1474.
(m, 2H),1.20–1.44 (m, 8H),1.13 (s, 9H), 0.88(t, J¼6.9 Hz, 3H); 13C NMR
(125 MHz, CDCl3)
d
156.4, 154.0, 135.0, 129.9, 118.4, 111.4, 90.9, 86.5,
4.2.13. Ethyl 1-(tert-butylamino)-3H-benzo[e]indole-2-carboxylate
(Table 2, entry 13)
55.6, 54.7, 54.0, 31.8, 29.7, 29.7, 29.5, 29.2, 26.0, 22.6,14.1; HRMS (ESI-
TOF) C21H34N2O2 calculated for [MþH]þ 347.2698, found 347.2696.
TLC: Rf¼0.30 (25% EtOAc/hexanes); IR (film) 3310, 2969, 1668,
1430,1263,1130 cmꢂ1; 1H NMR (500 MHz, CDCl3)
d
9.27 (d, J¼8.3 Hz,
4.2.7. N-tert-Butyl-6-methoxy-2-phenyl-1H-indol-3-amine (Table
2, entry 7)
1H), 9.05(br s,1H), 7.85 (d, J¼8.0 Hz,1H), 7.66(d, J¼8.9 Hz,1H), 7.56 (t,
J¼7.6 Hz, 1H), 7.43 (t, J¼7.5 Hz, 1H), 7.40 (d, J¼8.9 Hz, 1H), 4.46 (q,
J¼7.1 Hz,2H), 4.17(brs,1H),1.45(t, J¼7.1 Hz, 3H),1.26(s, 9H);13CNMR
TLC: Rf¼0.48 (20% EtOAc/hexanes); IR (film) 3349, 2968, 1622,
1166 cmꢂ1
;
1H NMR (500 MHz, CDCl3)
d
7.81 (dd, J¼8.3, 1.1 Hz,
(125 MHz, CDCl3) d 162.4, 133.9, 132.7, 129.8, 129.5, 128.3, 127.7, 125.5,
3H), 7.50 (d, J¼8.6 Hz, 1H), 7.43 (t, J¼7.8 Hz, 2H), 7.29 (t, J¼7.5 Hz,
1H), 6.83 (d, J¼2.2 Hz, 1H), 6.80 (dd, J¼8.7, 2.2 Hz, 1H), 3.87 (s,
3H), 2.84 (br s, 1H), 1.05 (s, 9H); 13C NMR (125 MHz, CDCl3)
125.0, 123.7, 119.4, 118.8, 112.9, 60.4, 56.8, 29.6, 14.5; HRMS (ESI-TOF)
C19H23N2O2 calculated for [MþH]þ 311.1759, found 311.1758.
d
156.5, 135.3, 133.9, 130.2, 128.6, 127.2, 126.9, 123.0, 120.2, 109.4,
4.2.14. Ethyl 3-(tert-butylamino)-5,6-dimethoxy-1H-indole-2-
carboxylate (Table 2, entry 14)
94.2, 55.7, 55.1, 30.4; HRMS (ESI-TOF) C19H23N2O calculated for
[MþH]þ 295.1810, found 295.1811.
TLC: Rf¼0.15 (25% EtOAc/hexanes); IR (film) 3348, 2971, 1684,
1540, 1256, 1173, 1094 cmꢂ1; 1H NMR (500 MHz, CDCl3)
d 8.59 (br s,
4.2.8. N-tert-Butyl-4,6-dimethoxy-2-(naphthalen-2-yl)-1H-indol-
3-amine (Table 2, entry 8)
1H), 7.16 (s, 1H), 6.67 (s, 1H), 4.70 (br s, 1H), 4.36 (q, J¼7.1 Hz, 2H),
3.87 (s, 3H), 3.83 (s, 3H), 1.37 (t, J¼7.1 Hz, 3H), 1.28 (s, 9H); 13C NMR
TLC: Rf¼0.90 (50% EtOAc/hexanes); IR (film) 3351 (br), 2958,
(125 MHz, CDCl3) d 162.4, 150.2, 144.8, 133.5, 131.2, 117.1, 116.1,
2904, 2387,1734,1601,1507,1453,1427,1387,1293,1266,1219,1199,
102.9, 93.3, 60.3, 56.0, 55.8, 54.8, 30.5, 14.5; HRMS (ESI-TOF)
1146,1126,1032 cmꢂ1; 1H NMR (500 MHz, CDCl3)
d
8.34 (d, J¼8.5 Hz,
C17H25N2O4 calculated for [MþH]þ 321.1814, found 321.1821.
1H), 8.09 (s,1H), 7.88 (br s, N–H,1H), 7.78–7.85 (m, 3H), 7.40–7.48 (m,
2H), 6.44 (s,1H), 6.18 (s,1H), 3.92 (s, 3H), 3.85 (s, 3H), 3.53 (br s, N–H,
4.2.15. Ethyl 5,6-dimethoxy-3-(4-methoxyphenylamino)-1H-
indole-2-carboxylate (Table 2, entry 15)
1H), 1.00 (s, 9H); 13C NMR (125 MHz, CDCl3)
d 157.6, 155.0, 136.2,
133.6,132.3,127.7,127.6,127.6,127.0,126.3,126.0,125.4,123.7,122.0,
112.7, 91.5, 86.6, 55.9, 55.6, 54.8, 29.9; HRMS (ESI-TOF) C24H26N2O2
calculated for [MþH]þ 375.2067, found 375.2062.
TLC: Rf¼0.23 (33% EtOAc/hexanes); IR (film); 3351, 2934, 1670,
1510, 1245, 1174, 1093 cmꢂ1 1H NMR (500 MHz, C6D6)
; d 7.76 (br s,
1H), 7.57 (br s, 1H), 7.01 (d, J¼8.8 Hz, 2H), 6.84 (s, 1H), 6.70 (d,
J¼8.8 Hz, 2H), 6.09 (s,1H), 4.17 (q, J¼7.1 Hz, 2H), 3.44 (s, 3H), 3.29 (s,
3H), 3.26 (s, 3H), 1.05 (t, J¼7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3)
4.2.9. Ethyl 3-(tert-butylamino)-1H-indole-2-carboxylate (Table 2,
entry 9)
d
162.4, 155.0, 150.6, 144.0, 136.5, 131.7, 121.4, 114.1, 112.1, 110.5,
TLC: Rf¼0.30 (25% EtOAc/hexanes); IR (film) 3154, 2976, 1689,
102.9, 93.6, 60.1, 56.0, 55.9, 55.6, 14.6; HRMS (ESI-TOF) C20H23N2O5
1544, 1252, 1098 cmꢂ1; 1H NMR (500 MHz, CDCl3)
d
8.34 (br s, 1H),
calculated for [MþH]þ 371.1606, found 371.1594.
7.84 (d, J¼8.3 Hz, 1H), 7.30 (m, 2H), 7.08 (ddd, J¼8.1, 4.9, 3.0 Hz, 1H),
4.42 (q, J¼7.1 Hz, 2H), 1.44 (t, J¼7.1 Hz, 3H), 1.35 (s, 9H); 13C NMR
4.2.16. Ethyl 3-(cyclohexylamino)-5,6-dimethoxy-1H-indole-2-
carboxylate (Table 2, entry 16)
(125 MHz, CDCl3)
d 162.7, 135.9, 134.0, 125.9, 123.2, 119.4, 116.5,
111.8, 60.4, 54.5, 30.7, 29.8, 14.6; HRMS (ESI-TOF) C15H21N2O2 cal-
TLC: Rf¼0.12 (25% EtOAc/hexanes); IR (film); 3356, 2931, 1665,
culated for [MþH]þ 261.1603, found 261.1598.
1489, 1256, 1172, 1096 cmꢂ1; 1H NMR (500 MHz, CDCl3)
d 7.74 (br s,
1H), 7.10 (s, 1H), 6.68 (s, 1H), 4.35 (q, J¼7.1 Hz, 2H), 3.91 (s, 6H), 3.70
(br s, 1H), 2.09 (d, J¼11.4 Hz, 2H), 1.79 (d, J¼13.0 Hz, 2H), 1.63 (d,
J¼13.2 Hz, 1H), 1.39 (t, J¼7.1 Hz, 3H), 1.31 (m, 5H); 13C NMR
4.2.10. Ethyl 7-(tert-butylamino)-5H-[1,3]dioxolo[4,5-f]indole-6-
carboxylate (Table 2, entry 10)
TLC: Rf¼0.30 (25% EtOAc/hexanes); IR (film) 3328, 2975,1682,1465,
(125 MHz, CDCl3) d 162.6, 150.8, 144.2, 132.5, 111.7, 103.0, 93.8, 59.6,
1251, 1038 cmꢂ1; 1H NMR (500 MHz, CDCl3)
d
8.22 (br s, 1H), 7.15 (s,
56.4, 55.9, 54.0, 34.3, 25.8, 24.8, 14.8; HRMS (ESI-TOF) C19H27N2O4
1H), 6.70 (s,1H), 5.96 (s, 2H), 4.67 (br s,1H), 4.38 (q, J¼7.1 Hz, 2H), 1.41 (t,
calculated for [MþH]þ 347.1970, found 347.1968.
J¼7.1 Hz, 3H), 1.29 (s, 9H); 13C NMR (125 MHz, CDCl3)
d 162.3, 148.2,
143.2, 132.0, 118.6, 116.5, 101.0, 100.4, 91.5, 60.2, 54.7, 30.6, 14.6; HRMS
4.2.17. (S)-Ethyl 5,6-dimethoxy-3-(1-phenylethylamino)-1H-
indole-2-carboxylate (Table 2, entry 17)
(ESI-TOF) C16H21N2O4 calculatedfor [MþH]þ 305.1501, found305.1499.
TLC: Rf¼0.30 (33% EtOAc/hexanes); IR (film) 3357, 2977, 1663,
4.2.11. Ethyl 3-(tert-butylamino)-6-methoxy-1H-indole-2-
carboxylate (Table 2, entry 11)
1490, 1336, 1257, 1174 cmꢂ1; 1H NMR (500 MHz, CDCl3)
d 7.69 (br s,
1H), 7.45 (d, J¼8.2 Hz, 2H), 7.31 (t, J¼7.7 Hz, 2H), 7.21 (t, J¼7.4 Hz,
1H), 6.80 (s, 1H), 6.59 (s, 1H), 5.01 (q, J¼6.5 Hz, 1H), 4.39 (q,
J¼7.1 Hz, 2H), 3.85 (s, 3H), 3.63 (s, 3H), 1.63 (d, J¼6.8 Hz, 3H), 1.41 (t,
TLC: Rf¼0.25 (20% EtOAc/hexanes); IR (film) 3336, 2972, 1684,
1628, 1254, 1095 cmꢂ1; 1H NMR (500 MHz, CDCl3)
d 8.20 (br s, 1H),
7.70 (d, J¼9.0 Hz, 1H), 6.73 (dd, J¼9.0, 2.1 Hz, 1H), 6.69 (d, J¼2.1 Hz,
J¼7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3)
d 162.5, 150.5, 146.2,
143.8, 132.3, 128.6, 126.8, 125.6, 103.1, 93.4, 59.6, 56.1, 55.7, 55.5,
1H), 5.02 (br s,1H), 4.39 (q, J¼7.1 Hz, 2H), 3.84 (s, 3H),1.42 (t, J¼7.1 Hz,
3H),1.34(s, 9H);13CNMR(125 MHz,CDCl3)
d
162.6, 159.2, 137.2, 124.2,
25.8, 14.7; [
a]
158 (c 1.0, CHCl3); HRMS (ESI-TOF) C21H25N2O4
D
20
118.1, 114.9, 110.7, 93.3, 60.1, 55.4, 54.3, 30.7, 29.8, 14.6; HRMS (ESI-
calculated for [MþH]þ 369.1814, found 321.1815.
TOF) C16H23N2O3 calculated for [MþH]þ 291.1708, found 291.1704.
4.3. General procedure for the synthesis of indoxyls (40,60-
dimethoxyspiro[cyclohexane-1,20-indolin]-30-one, Table 3,
entry 1)
4.2.12. Ethyl 3-(tert-butylamino)-6-(methylthio)-1H-indole-2-
carboxylate (Table 2, entry 12)
TLC: Rf¼0.42 (25% EtOAc/hexanes); IR (film); 3337, 2974, 1673,
1560, 1230, 675 cmꢂ1
;
1H NMR (500 MHz, CDCl3)
d
8.16 (br s, 1H),
tert-Butylisocyanide (52 mg, 0.62 mmol,1.5 equiv) and a solution
of 175 mg acid 2 (0.46 mmol, 1.1 equiv) in 3.3 mL dichloromethane
were added via syringe to a solution of imine (100 mg, 0.41 mmol,
1.0 equiv) in dichloromethane (5 mL). The resulting solution was
7.73 (d, J¼8.6 Hz, 1H), 7.14 (s, 1H), 7.00 (d, J¼8.7 Hz, 1H), 4.96 (br s,
1H), 4.40 (q, J¼7.1 Hz, 2H), 2.54 (s, 3H), 1.43 (t, J¼7.1 Hz, 3H), 1.34 (s,
9H); 13C NMR (125 MHz, CDCl3)
d 162.6, 136.5, 136.4, 123.4, 121.7,